Literature DB >> 20557331

The prevalence of peripheral arterial disease in patients with heart failure by race and ethnicity.

Kathy Hebert1, Barbara Lopez, Christina Michael, Emiliana Franco, Andre Dias, Pat Trahan, Shi Huang, Leonardo Tamariz, Lee Arcement.   

Abstract

More than 5 million people live with heart failure (HF) in the United States, and this number is expected to rise due to several factors including increased life expectancy brought about by medical therapy and the aging of the population. HF and peripheral arterial disease (PAD) share many risk factors. A review of the literature reveals several studies supporting a higher prevalence of HF in patients with PAD than in those without PAD. However, no study was found that estimates the prevalence of PAD in patients with HF. Moreover, the prevalence of PAD by US race/ethnic groups with HF has not been studied. The authors conducted a cross-sectional multicenter study of patients enrolled in an HF disease management program in Louisiana (n=330) and Florida (n=464). All patients with an ejection fraction <or=40% and a measured ankle-brachial index (ABI) were included in the study. PAD was defined as an ABI <0.9. The overall prevalence of PAD was 17.1%. The prevalence of PAD was 25.9% for white, 13.4% for Hispanic, and 13.7% for black patients. White patients had a higher prevalence of PAD than black or Hispanic patients (P<.001). Routine ABI measurements in these groups would enhance efforts to detect subclinical PAD. (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20557331     DOI: 10.1111/j.1751-7133.2010.00140.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  6 in total

Review 1.  Peripheral arterial disease and chronic heart failure: a dangerous mix.

Authors:  Sally C Inglis; Adriana Hermis; Sajad Shehab; Phillip J Newton; Sara Lal; Patricia M Davidson
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

2.  Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).

Authors:  Jorge Silva Enciso; Tomoko S Kato; Zhezhen Jin; Christine Chung; Jonathan Yang; Hiroo Takayama; Donna M Mancini; P Christian Schulze
Journal:  Am J Cardiol       Date:  2014-07-17       Impact factor: 2.778

3.  Improvement of arterial stiffness in the transition from acute decompensated heart failure to chronic compensated heart failure.

Authors:  Dong-Bin Kim; Sang Hong Baek; Sung Won Jang; Sung-Ho Her; Dong-Il Shin; Chan Seok Park; Hoon Joon Park; Pum Joon Kim; Hae Ok Jung; Ki Bae Seung
Journal:  Clin Cardiol       Date:  2013-04-12       Impact factor: 2.882

4.  Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Line Melgaard; Anders Gorst-Rasmussen; Lars Hvilsted Rasmussen; Gregory Y H Lip; Torben Bjerregaard Larsen
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

5.  Impact of peripheral arterial disease on functional limitation in congestive heart failure: results from the national health and nutrition examination survey (1999-2004).

Authors:  Bamidele A Adesunloye; Ravinder Valadri; Nkechi M Mbaezue; Anekwe E Onwuanyi
Journal:  Cardiol Res Pract       Date:  2012-12-17       Impact factor: 1.866

6.  Recurrent Admissions for Acute Decompensated Heart Failure Among Patients With and Without Peripheral Artery Disease: The ARIC Study.

Authors:  Zainali Chunawala; Patricia P Chang; Andrew P DeFilippis; Michael E Hall; Kunihiro Matsushita; Melissa C Caughey
Journal:  J Am Heart Assoc       Date:  2020-10-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.